7 Followers on Owler
Conexio develops novel genetic sequencing and mutation detection products and services... Read more
OverviewNews & Insights
Conexio develops novel genetic sequencing and mutation detection products and services... Read more
Conexio Genomics Founder & CEO: David Sayer

Founder & CEO

David Sayer

CEO Approval Rating

67/100

2002

Private

Pharmaceuticals & Biotechnology
Life Sciences
2836 NAICS listing

Est. Annual Revenue
<$1M
Agree?
Est. Employees
100-250
Agree?

News

May 10, 2017
Conexio Blog
Conexio Blog CareDx has acquired HLA SBT business from Illumina
Jan 23, 2017
Reuters
Conexio: BRIEF-CareDx's unit entered into a business sale agreement with Conexio Genomics Pty - SEC Filing
Jan 22, 2017
Genomeweb
Conexio: CareDx to Purchase HLA Typing Assets From Conexio Genomics
Nov 10, 2016
Conexio Blog
Conexio Blog Notice to Assign Users: 3.27.0 January 2017 Reference Update
Jul 08, 2016
Conexio Blog
Conexio Blog Health Canada Approval
Jul 08, 2016
Conexio Blog
Conexio Blog January 2016 Reference Updates
Jul 08, 2016
Conexio Blog
Conexio Blog Introducing GAMMA-TYPE
Jul 08, 2016
Conexio Blog
Conexio Blog TGA Approval
Jul 08, 2016
Conexio Blog
Conexio Blog Celera January 2016 Reference Updates
Jul 08, 2016
Conexio Blog
Conexio Blog Assign SBT v4.7.1 Software Update

Trending Companies